Prostate cancer: PARP inhibitors in prostate cancer - What nurses need to know

December 06, 2023 00:24:43
Prostate cancer: PARP inhibitors in prostate cancer - What nurses need to know
COR2ED - Oncology Medical Conversation
Prostate cancer: PARP inhibitors in prostate cancer - What nurses need to know

Dec 06 2023 | 00:24:43

/

Show Notes

COR2ED Medical Education: Pablo Peinado, Research Nurse Coordinator, and Dr. Elena Castro, medical oncologist, who both work at Hospital Universitario Virgen de la Victoria in Malaga in Spain, discuss ‘The potential of PARP inhibitors in prostate cancer: What nurses need to know’. 

In this podcast, the experts discuss PARP inhibitors (PARPi’s), how they work and key data from the registration trials for rucaparib and olaparib, TRITON2 and PROfound.  They also discuss how to select PARPi’s for their prostate cancer patients and where they fit in the overall treatment sequence. Pablo provides some insight into communicating with patients, and the types of questions and concerns they often have in relation to genetic testing and treatment with PARPi’s.  In addition, they also discuss the PARPi’s currently in late-stage development such as niraparib and talazoparib as well as the potential future use of PARPi’s in combination with immunotherapies or androgen receptor pathway inhibitors.

Other Episodes

Episode

December 06, 2023 00:19:51
Episode Cover

Advanced RCC: Clinical implementation of targeted therapies and immunotherapies

Prof. Thomas Powles, a Medical Oncologist from Barts Cancer Centre in the UK and Dr Friederike Schlürmann a Medical Oncologist from University Hospital of...

Listen

Episode

November 08, 2024 00:25:50
Episode Cover

BRAF-mutated CRC: testing to treatment

Experts Prof. Sebastian Stintzing and Dr Thomas Winder discuss the significance of BRAF mutations in colorectal cancer (CRC), and the testing strategies and available...

Listen

Episode

December 06, 2023 00:21:28
Episode Cover

Upper GI cancer: Update from ESMO 2022 - Part 2

This second GI CONNECT podcast episode, covers the highlights on gastroesophageal cancer from ESMO 2022.  Dr Sam Klempner (Massachusetts General Hospital, Boston, USA) and...

Listen